SCHEMBL14184071

SCHEMBL14184071

C=C(I)CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4108533 0.69 — —
SCHEMBL12967665 0.67 — —
SCHEMBL13590059 0.67 — —
SCHEMBL6448143 0.67 — —
SCHEMBL636736 0.67 — —
SCHEMBL18198523 0.64 — —
SCHEMBL12954888 0.64 — —
SCHEMBL8925633 0.64 — —
SCHEMBL131732 0.64 — —
SCHEMBL15803400 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7390831-B2 contraception, secondary amenorrhea; dysfunctional bleeding; uterine leiomyomata; endometriosis; polycystic ovary syndrome; carcinomas, adenocarcinomas, Syndrome X, diabetes; 3'H-spiro-[[1,3]-dioxol-11,12-Dihydroxy-13-methyl-1,6,7,8,11,12,13,14,15,16-decahydro-2H-cyclopenta[a]phenanthrene-3,17-dione JANSSEN PHARMACEUTICA N.V. (BE) 2008-06-24 — — US disclosed
US-20070197634-A1 TETRACYCLIC STEROID DERIVATIVES USEFUL AS PROGESTERONE RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2007-08-23 — — US disclosed
Send feedback